31-Jul-2026
Cardinal Health Buys AdaptHealth’s Diabetes Health Unit: What It Means for AHCO’s Future
Market Chameleon (Tue, 21-Jul 3:51 AM ET)
Cardinal Health expands home care business with two tuck-in acquisitions
PRNewswire (Mon, 20-Jul 4:45 PM ET)
Business Wire (Mon, 20-Jul 4:30 PM ET)
AdaptHealth Corp. Announces Second Quarter 2026 Earnings Release Date and Conference Call
Business Wire (Tue, 14-Jul 4:05 PM ET)
AdaptHealth Corp. to Participate in Upcoming Investor Conferences
Business Wire (Tue, 5-May 4:05 PM ET)
Market Chameleon (Tue, 5-May 4:55 AM ET)
AdaptHealth Corp. Announces First Quarter 2026 Results
Business Wire (Tue, 5-May 7:00 AM ET)
AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. The Company operates under four reportable segments that align with its product categories: (i) Sleep Health, (ii) Respiratory Health, (iii) Diabetes Health, and (iv) Wellness at Home. The company generates majority of its revenue from the Sleep Health segment. The Sleep Health segment provides sleep therapy equipment, supplies and related services (including continuous positive airway pressure and BiLevel services) to individuals for the treatment of obstructive sleep apnea.
Adapthealth Corp. trades on the NASDAQ stock market under the symbol AHCO.
As of July 31, 2026, AHCO stock price climbed to $10.80 with 679,494 million shares trading.
AHCO has a beta of -0.07, meaning it tends to be less sensitive to market movements. AHCO has a correlation of 0.00 to the broad based SPY ETF.
AHCO has a market cap of $1.47 billion. This is considered a Small Cap stock.
Last quarter Adapthealth Corp. reported $820 million in Revenue and -$.05 earnings per share. This beat revenue expectation by $23 million and missed earnings estimates by -$.04.
In the last 3 years, AHCO traded as high as $15.37 and as low as $6.37.
The top ETF exchange traded funds that AHCO belongs to (by Net Assets): IJR, VTI, IWM, VB, VBR.
AHCO has outperformed the market in the last year with a return of +20.4%, while the SPY ETF gained +19.4%. However, in the most recent history, AHCO shares have underperformed the stock market with its stock returning -17.6% in the last 3 month period and -1.5% for the last 2 week period, while SPY has returned +4.2% and +0.5%, respectively.
AHCO support price is $10.38 and resistance is $10.98 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AHCO shares will trade within this expected range on the day.